WEED 2: Cannabis Madness CNN Special Report by Dr Sanjay Gupta (2014)
- 6 years ago
Cannabis Madness takes a look at U.S. federal laws that consider marijuana a drug with no medicinal value and serious scientists who say they're wrong. It is the politics of pot - the politicians vs. the patients as CNN's award-winning chief medicine reporter & neurosurgeon, Dr. Sanjay Gupta puts medical marijuana under the microscope again to better understand the therapeutic uses of CBD, CBD Oil and cannabinoids. CBD Oil comes from marijuana's non-psychoactive cannabis cousin, industrial HEMP. CBD is not psychoactive and is a natural constituent of hemp oil (all hemp products have CBD in them).
Dr. Sanjay Gupta calls marijuana a plant “that can work wonders” and presents the plight of families who are using the drug to help ailing children to make his larger case: that legal restrictions on the drug are keeping needy patients from potentially lifesaving medicine.
In 2014 the federal government began to give medical marijuana research a yellow light and first study of cannabis’ effects on epilepsy that was approved by the Food and Drug Administration to allow a handful of U.S. doctors to administer a drug called Epidiolex to young patients. Epidiolex is an extract that has extremely low levels of THC - the substance in marijuana that gets users high - and high levels of a substance called cannabidiol, known as CBD.
Visit CBD Insiders, a fast-growing community sharing their knowledge of the latest CBD Health, CBD Research, CBD Science & CBD News as well as exclusive interviews and in-depth reporting on influential players in the CBD business.
https://cbdinsiders.com.au/
Dr. Sanjay Gupta calls marijuana a plant “that can work wonders” and presents the plight of families who are using the drug to help ailing children to make his larger case: that legal restrictions on the drug are keeping needy patients from potentially lifesaving medicine.
In 2014 the federal government began to give medical marijuana research a yellow light and first study of cannabis’ effects on epilepsy that was approved by the Food and Drug Administration to allow a handful of U.S. doctors to administer a drug called Epidiolex to young patients. Epidiolex is an extract that has extremely low levels of THC - the substance in marijuana that gets users high - and high levels of a substance called cannabidiol, known as CBD.
Visit CBD Insiders, a fast-growing community sharing their knowledge of the latest CBD Health, CBD Research, CBD Science & CBD News as well as exclusive interviews and in-depth reporting on influential players in the CBD business.
https://cbdinsiders.com.au/